Fineline Cube

Follow:
14435 Articles
CompanyDeals

RemeGen and Allist Partner to Assess ADC and EGFR Inhibitor Combination in NSCLC

CompanyDrug

HealZen Therapeutics Gains NMPA Approval for HZ-A-018 Clinical Study in Autoimmune Diseases

CompanyDrug

Betta Pharmaceuticals’ BPI-D0316 Accepted for Review by CDE for First-Line NSCLC

CompanyDrug

Jiangsu Alpha Biopharma’s Zorifertinib NDA Accepted for Review by CDE

CompanyDrug

Grand Pharma’s Jext Auto-Injector Approved for Import into Greater Bay Area

CompanyDrug

Abbisko’s ABSK021 Receives FDA Breakthrough Therapy Designation for TGCT

CompanyDrug

CDE Grants Priority Review Status to Kechow’s HL-085 for Melanoma Treatment

CompanyDrug

NMPA Approves Two China-Developed COVID-19 Small-Molecule Therapies

Policy / Regulatory

China’s NHC Issues Guidelines to Improve Pediatric Medication Management

Policy / Regulatory

China’s Multi-Bureau Plan Aims to Eradicate Cervical Cancer by 2030

CompanyDrug

JS InnoPharm’s US Subsidiary Initiates Phase I Trial for AURKA Inhibitor VIC-1911

CompanyDeals

Akeso Receives First $300M Installment from Summit for Bispecific Antibody Ivonescimab